Presentation is loading. Please wait.

Presentation is loading. Please wait.

Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials  Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,

Published byJob Summers Modified over 5 years ago

Similar presentations

Presentation on theme: "Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials  Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,"— Presentation transcript:

1 Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials  Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD, Thomas A. D'Amico, MD, Mark F. Berry, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 151, Issue 3, Pages (March 2016) DOI: /j.jtcvs Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

2 Survival of patients with unsuspected N2 disease stratified by therapy.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials  Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,"

Similar presentations

A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non–small cell lung cancer  Babatunde A. Yerokun, MD, Chi-Fu.

A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non–small cell lung cancer  Babatunde A. Yerokun, MD, Chi-Fu.
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 

Manuel J. Antunes, MD, PhD, DSc 
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients  Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients  Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 

One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,
Lung cancer screening: No more excuses

Lung cancer screening: No more excuses
Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J
Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 
Neel R. Sodha, MD, Frank W. Sellke, MD 

Neel R. Sodha, MD, Frank W. Sellke, MD 
Ground glass opacity of the lung: The veil that needs lifting

Ground glass opacity of the lung: The veil that needs lifting
Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer  Paul J. Speicher, MD, Zachary W. Fitch,

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer  Paul J. Speicher, MD, Zachary W. Fitch,
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 

Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Marc R. Moon, MD  The Journal of Thoracic and Cardiovascular Surgery 

Marc R. Moon, MD  The Journal of Thoracic and Cardiovascular Surgery 
A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer  Brian C. Gulack, MD, Chi-Fu Jeffrey Yang,

A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer  Brian C. Gulack, MD, Chi-Fu Jeffrey Yang,
Go on-pump or off-pump in diabetic patients?

Go on-pump or off-pump in diabetic patients?
New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum  Martin Czerny, MD, MBA  The Journal.

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum  Martin Czerny, MD, MBA  The Journal.

Similar presentations

Ads by Google